Here's the live share price of Senores Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals | 11.78 | 3.57 | 51.98 | 89.11 | 118.13 | 38.60 | 21.63 |
| Sun Pharmaceutical Industries | -0.06 | 0.98 | 6.49 | 14.41 | 18.50 | 19.63 | 20.09 |
| Divi's Laboratories | 2.51 | 22.60 | 25.14 | 37.78 | 39.27 | 31.58 | 11.42 |
| Torrent Pharmaceuticals | -1.79 | -1.45 | 13.53 | 19.69 | 34.78 | 35.26 | 26.89 |
| Zydus Lifesciences | 6.03 | 3.71 | 24.93 | 29.63 | 18.60 | 22.28 | 16.00 |
| Cipla | -0.95 | 2.40 | 10.09 | 9.78 | -6.46 | 5.76 | 10.31 |
| Lupin | -5.46 | -9.48 | 2.06 | 2.81 | 13.66 | 27.86 | 18.28 |
| Dr. Reddy's Laboratories | 2.64 | -2.32 | -4.67 | -4.86 | -3.72 | 1.19 | 5.31 |
| Mankind Pharma | -0.53 | -3.64 | 0.44 | 17.36 | -1.93 | 9.97 | 11.17 |
| Laurus Labs | 0.28 | 18.20 | 43.79 | 82.26 | 113.22 | 68.53 | 21.09 |
| Aurobindo Pharma | 4.22 | 6.90 | 10.62 | 44.24 | 53.79 | 23.86 | 16.83 |
| Biocon | -4.91 | 1.33 | -0.42 | 10.11 | 15.49 | 17.79 | 2.30 |
| Alkem Laboratories | -3.38 | -2.80 | -0.66 | 0.32 | 0.52 | 12.64 | 8.15 |
| Glenmark Pharmaceuticals | -0.21 | -0.31 | 0.70 | 14.91 | 12.92 | 42.22 | 32.43 |
| Abbott India | -0.93 | 0.88 | 1.34 | 4.37 | -16.25 | 5.38 | 7.77 |
| Anthem Biosciences | 5.88 | 16.95 | 7.93 | 26.89 | 15.81 | 6.17 | 3.66 |
| Gland Pharma | 12.70 | 19.90 | 59.93 | 65.76 | 51.26 | 22.56 | -7.20 |
| Ipca Laboratories | 3.53 | -1.61 | 19.08 | 20.56 | 31.56 | 26.63 | 8.58 |
| Ajanta Pharma | 4.15 | 5.62 | 15.81 | 23.88 | 35.52 | 27.90 | 19.28 |
| GlaxoSmithKline Pharmaceuticals | 2.49 | 9.37 | 9.84 | 1.92 | -4.68 | 23.14 | 10.45 |
Source: Dion Global
Over the last one year, Senores Pharmaceuticals has gained 118.13% compared to peers like Sun Pharmaceutical Industries (18.50%), Divi's Laboratories (39.27%), Torrent Pharmaceuticals (34.78%). From a 5 year perspective, Senores Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (20.09%) and Divi's Laboratories (11.42%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,378.5 | 1,402.11 |
| 10 | 1,352.18 | 1,379.4 |
| 20 | 1,377.91 | 1,367.9 |
| 50 | 1,309.51 | 1,294.39 |
| 100 | 1,106.72 | 1,165.1 |
| 200 | 949.88 | 1,004.36 |
Source: Dion Global
In the latest quarter, Senores Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 9.77%, FII holding rose to 6.62%, and public shareholding moved down to 37.78% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 6,08,772 | 0.45 | 80.96 | |
| 4,70,630 | 0.42 | 62.59 | |
| 4,33,663 | 2.09 | 57.67 | |
| 90,000 | 1.32 | 11.97 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Aug 04, 2026, 11:22 PM IST IST | Senores Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Aug 04, 2026, 11:19 PM IST IST | Senores Pharma. - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Aug 03, 2026, 08:48 PM IST IST | Senores Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Jul 28, 2026, 12:57 AM IST IST | Senores Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Jul 27, 2026, 11:23 PM IST IST | Senores Pharma. - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue |
Source: Dion Global
Senores Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 26/12/2017 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24290GJ2017PLC100263 and registration number is 100263. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 106.09 Cr. and Equity Capital is Rs. 46.05 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Senores Pharmaceuticals is ₹1,485.00 as on Aug 13, 2026.
The Senores Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Senores Pharmaceuticals is ₹6,838.96 Cr as on Aug 13, 2026.
Today’s highest and lowest price of Senores Pharmaceuticals are ₹1,510.70 and ₹1,471.50.
The 52-week high/low is the highest and lowest price at which Senores Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Senores Pharmaceuticals is ₹1,509.20 and 52-week low of Senores Pharmaceuticals is ₹641.25 as on Aug 13, 2026.
The Senores Pharmaceuticals has shown returns of -0.39% over the past day, 3.57% for the past month, 51.98% over 3 months, 118.13% over 1 year, 38.6% across 3 years, and 21.63% over 5 years.
P/E ratio of and PB ratio of Senores Pharmaceuticals are 54.12 and 7.33 on Aug 13, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global